Yogurt supplemented with probiotics can protect the healthy elderly from respiratory infections: A randomized controlled open-label trial

Fangfang Pu,1,* Yue Guo,1,2,* Ming Li,1 Hong Zhu,3 Shijie Wang,3 Xi Shen,1 Miao He,1 Chengyu Huang,1 Fang He1 1Department of Nutrition, Food Safety and Toxicology, West China School of Public Health, Sichuan University, Chengdu, Sichuan, People’s Republic of China; 2Microbiology laborator...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Pu F, Guo Y, Li M, Zhu H, Wang S, Shen X, He M, Huang C, He F
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://doaj.org/article/d75dbd505a744d4781e9972cab354a83
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d75dbd505a744d4781e9972cab354a83
record_format dspace
spelling oai:doaj.org-article:d75dbd505a744d4781e9972cab354a832021-12-02T00:36:37ZYogurt supplemented with probiotics can protect the healthy elderly from respiratory infections: A randomized controlled open-label trial1178-1998https://doaj.org/article/d75dbd505a744d4781e9972cab354a832017-08-01T00:00:00Zhttps://www.dovepress.com/yoghurt-supplemented-with-probiotics-can-protect-the-healthy-elderly-f-peer-reviewed-article-CIAhttps://doaj.org/toc/1178-1998Fangfang Pu,1,* Yue Guo,1,2,* Ming Li,1 Hong Zhu,3 Shijie Wang,3 Xi Shen,1 Miao He,1 Chengyu Huang,1 Fang He1 1Department of Nutrition, Food Safety and Toxicology, West China School of Public Health, Sichuan University, Chengdu, Sichuan, People’s Republic of China; 2Microbiology laboratory, Chengdu Center for Disease Control & Prevention, Chengdu, Sichuan, People’s Republic of China; 3R&D center, Shijiazhuang Junlebao Dairy Co. Ltd., Shijiazhuang, Hebei, People’s Republic of China *These authors contributed equally to this work Purpose: To evaluate whether yogurt supplemented with a probiotic strain could protect middle-aged and elderly people from acute upper respiratory tract infections (URTI) using a randomized, blank-controlled, parallel-group design.Patients and methods: Two hundred and five volunteers aged ≥45 years were randomly divided into two groups. The subjects in the intervention group were orally administered 300 mL/d of yogurt supplemented with a probiotic strain, Lactobacillus paracasei N1115 (N1115), 3.6×107 CFU/mL for 12 weeks, while those in the control group retained their normal diet without any probiotic supplementation. The primary outcome was the incidence of URTI, and changes in serum protein, immunoglobulins, and the profiles of the T-lymphocyte subsets (total T-cells [CD3+], T-helper cells [CD4+], and T-cytotoxic-suppressor cells [CD8+]) during the intervention were the secondary outcomes.Results: Compared to the control group, the number of persons diagnosed with an acute URTI and the number of URTI events significantly decreased in the intervention group (P=0.038, P=0.030, respectively). The risk of URTI in the intervention group was evaluated as 55% of that in the control group (relative risk =0.55, 95% CI: 0.307–0.969). The change in the percentage of CD3+ cells in the intervention group was significantly higher than in the control group (P=0.038). However, no significant differences were observed in the total protein, albumin, globulin, and prealbumin levels in both groups (P>0.05).Conclusion: The study suggested that yogurt with selected probiotic strains such as N1115 may reduce the risk of acute upper tract infections in the elderly. The enhancement of the T-cell-mediated natural immune defense might be one of the important underlying mechanisms for probiotics to express their anti-infective effects. Keywords: yogurt, probiotics, Lactobacillus paracasei N1115, immunosenescence, acute upper respiratory tract infection, elderlyPu FGuo YLi MZhu HWang SShen XHe MHuang CHe FDove Medical PressarticleYogurtProbioticsLactobacillus paracasei N1115immunosenescenceacute upper respiratory tract infectionelderlyGeriatricsRC952-954.6ENClinical Interventions in Aging, Vol Volume 12, Pp 1223-1231 (2017)
institution DOAJ
collection DOAJ
language EN
topic Yogurt
Probiotics
Lactobacillus paracasei N1115
immunosenescence
acute upper respiratory tract infection
elderly
Geriatrics
RC952-954.6
spellingShingle Yogurt
Probiotics
Lactobacillus paracasei N1115
immunosenescence
acute upper respiratory tract infection
elderly
Geriatrics
RC952-954.6
Pu F
Guo Y
Li M
Zhu H
Wang S
Shen X
He M
Huang C
He F
Yogurt supplemented with probiotics can protect the healthy elderly from respiratory infections: A randomized controlled open-label trial
description Fangfang Pu,1,* Yue Guo,1,2,* Ming Li,1 Hong Zhu,3 Shijie Wang,3 Xi Shen,1 Miao He,1 Chengyu Huang,1 Fang He1 1Department of Nutrition, Food Safety and Toxicology, West China School of Public Health, Sichuan University, Chengdu, Sichuan, People’s Republic of China; 2Microbiology laboratory, Chengdu Center for Disease Control & Prevention, Chengdu, Sichuan, People’s Republic of China; 3R&D center, Shijiazhuang Junlebao Dairy Co. Ltd., Shijiazhuang, Hebei, People’s Republic of China *These authors contributed equally to this work Purpose: To evaluate whether yogurt supplemented with a probiotic strain could protect middle-aged and elderly people from acute upper respiratory tract infections (URTI) using a randomized, blank-controlled, parallel-group design.Patients and methods: Two hundred and five volunteers aged ≥45 years were randomly divided into two groups. The subjects in the intervention group were orally administered 300 mL/d of yogurt supplemented with a probiotic strain, Lactobacillus paracasei N1115 (N1115), 3.6×107 CFU/mL for 12 weeks, while those in the control group retained their normal diet without any probiotic supplementation. The primary outcome was the incidence of URTI, and changes in serum protein, immunoglobulins, and the profiles of the T-lymphocyte subsets (total T-cells [CD3+], T-helper cells [CD4+], and T-cytotoxic-suppressor cells [CD8+]) during the intervention were the secondary outcomes.Results: Compared to the control group, the number of persons diagnosed with an acute URTI and the number of URTI events significantly decreased in the intervention group (P=0.038, P=0.030, respectively). The risk of URTI in the intervention group was evaluated as 55% of that in the control group (relative risk =0.55, 95% CI: 0.307–0.969). The change in the percentage of CD3+ cells in the intervention group was significantly higher than in the control group (P=0.038). However, no significant differences were observed in the total protein, albumin, globulin, and prealbumin levels in both groups (P>0.05).Conclusion: The study suggested that yogurt with selected probiotic strains such as N1115 may reduce the risk of acute upper tract infections in the elderly. The enhancement of the T-cell-mediated natural immune defense might be one of the important underlying mechanisms for probiotics to express their anti-infective effects. Keywords: yogurt, probiotics, Lactobacillus paracasei N1115, immunosenescence, acute upper respiratory tract infection, elderly
format article
author Pu F
Guo Y
Li M
Zhu H
Wang S
Shen X
He M
Huang C
He F
author_facet Pu F
Guo Y
Li M
Zhu H
Wang S
Shen X
He M
Huang C
He F
author_sort Pu F
title Yogurt supplemented with probiotics can protect the healthy elderly from respiratory infections: A randomized controlled open-label trial
title_short Yogurt supplemented with probiotics can protect the healthy elderly from respiratory infections: A randomized controlled open-label trial
title_full Yogurt supplemented with probiotics can protect the healthy elderly from respiratory infections: A randomized controlled open-label trial
title_fullStr Yogurt supplemented with probiotics can protect the healthy elderly from respiratory infections: A randomized controlled open-label trial
title_full_unstemmed Yogurt supplemented with probiotics can protect the healthy elderly from respiratory infections: A randomized controlled open-label trial
title_sort yogurt supplemented with probiotics can protect the healthy elderly from respiratory infections: a randomized controlled open-label trial
publisher Dove Medical Press
publishDate 2017
url https://doaj.org/article/d75dbd505a744d4781e9972cab354a83
work_keys_str_mv AT puf yogurtsupplementedwithprobioticscanprotectthehealthyelderlyfromrespiratoryinfectionsarandomizedcontrolledopenlabeltrial
AT guoy yogurtsupplementedwithprobioticscanprotectthehealthyelderlyfromrespiratoryinfectionsarandomizedcontrolledopenlabeltrial
AT lim yogurtsupplementedwithprobioticscanprotectthehealthyelderlyfromrespiratoryinfectionsarandomizedcontrolledopenlabeltrial
AT zhuh yogurtsupplementedwithprobioticscanprotectthehealthyelderlyfromrespiratoryinfectionsarandomizedcontrolledopenlabeltrial
AT wangs yogurtsupplementedwithprobioticscanprotectthehealthyelderlyfromrespiratoryinfectionsarandomizedcontrolledopenlabeltrial
AT shenx yogurtsupplementedwithprobioticscanprotectthehealthyelderlyfromrespiratoryinfectionsarandomizedcontrolledopenlabeltrial
AT hem yogurtsupplementedwithprobioticscanprotectthehealthyelderlyfromrespiratoryinfectionsarandomizedcontrolledopenlabeltrial
AT huangc yogurtsupplementedwithprobioticscanprotectthehealthyelderlyfromrespiratoryinfectionsarandomizedcontrolledopenlabeltrial
AT hef yogurtsupplementedwithprobioticscanprotectthehealthyelderlyfromrespiratoryinfectionsarandomizedcontrolledopenlabeltrial
_version_ 1718403648842629120